Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

Anemia

Free Subscription Articles published in Haematologica Retrieve available abstracts of 92 articles: HTML format

Single Articles

September 2025
1. NAKAO S
   Romiplostim for aplastic anemia: beyond an eltrombopag alternative.
   Haematologica. 2025 Sep 4. doi: 10.3324/haematol.2025.288632.
   PubMed     Abstract available
   
   
   July 2025
2. BORDBAR M, Faghihi A, Zekavat OR, Shahriari M, et al
   Safety and efficacy of romiplostim in children with acquired aplastic anemia who are naive to immunosuppressive therapy.
   Haematologica. 2025 Jul 24. doi: 10.3324/haematol.2025.288078.
   PubMed     Abstract available
   
   
   
3. PRATA PH, Eikema DJ, Piepenbroek B, Kulasekararaj A, et al
   Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia Report.
   Haematologica. 2025 Jul 3. doi: 10.3324/haematol.2024.287205.
   PubMed     Abstract available
   
   
   June 2025
4. MOZESSOHN L, Buckstein R
   Should we move past erythropoietin-stimulating agent monotherapy in lower-risk myelodysplastic syndromes?
   Haematologica. 2025 Jun 26. doi: 10.3324/haematol.2025.288157.
   PubMed     Abstract available
   
   
   
5. BERNAUDIN F, Arnaud C, Kamdem A, Youn J, et al
   Early detection and management of extracranial arteriopathy reduces the incidence of silent cerebral infarcts in sickle cell anemia: a long-term prospective cohort study.
   Haematologica. 2025 Jun 26. doi: 10.3324/haematol.2025.287720.
   PubMed     Abstract available
   
   
   
6. MEI C, Xu G, Zheng C, Xie Y, et al
   Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.
   Haematologica. 2025 Jun 12. doi: 10.3324/haematol.2024.287055.
   PubMed     Abstract available
   
   
   
7. BEYAR-KATZ O, Rejeski K, Shouval R
   Immune effector cell-associated hematotoxicity: mechanisms, clinical manifestations, and management strategies.
   Haematologica. 2025;110:1254-1268.
   PubMed     Abstract available
   
   
   May 2025
8. PARISI L, Escher R
   Myopathy, lactic acidosis and sideroblastic anemia syndrome 1 (MLASA1) : clinical hallmarks in a large pedigree with a novel PUS1 R144Q mutation, remarkable response to somatropin, and review of the literature.
   Haematologica. 2025 May 29. doi: 10.3324/haematol.2025.287393.
   PubMed     Abstract available
   
   
   
9. OVED JH, Bacigalupo A, DeZern AE
   Towards graft-versus-host disease-free alternative donor transplant platforms for patients with acquired aplastic anemia.
   Haematologica. 2025 May 29. doi: 10.3324/haematol.2024.286544.
   PubMed     Abstract available
   
   
   
10. BRANDSEN RP, Diederen RMH, Kocabas G, Nur E, et al
    Clinical and laboratory risk factors for sickle cell retinopathy and maculopathy: a scoping review of the current evidence.
    Haematologica. 2025;110:1092-1104.
    PubMed     Abstract available
    
    
    April 2025
11. SHAMIR G, Rouvio O, Reiner-Benaim A
    Prognostic and biological characteristics associated with multiple myeloma presenting only with anemia.
    Haematologica. 2025 Apr 30. doi: 10.3324/haematol.2024.286457.
    PubMed     Abstract available
    
    
    
12. DANIELS DE, Hawksworth J, El Hoss S, Oyawoye FO, et al
    Optimizing CRISPR methodology for precise gene editing in the erythroid cell line BEL-A with high efficiency generation of a sickle cell anemia model.
    Haematologica. 2025 Apr 10. doi: 10.3324/haematol.2024.287221.
    PubMed     Abstract available
    
    
    March 2025
13. KOO J, Snyder AJ, Campbell K, Miller E, et al
    Hepatocyte senescence and persistent liver injury in Fanconi anemia.
    Haematologica. 2025 Mar 6. doi: 10.3324/haematol.2024.287096.
    PubMed     Abstract available
    
    
    
14. SCOURFIELD LEA, Nardo-Marino A, Williams TN, Rees DC, et al
    Infections in sickle cell disease.
    Haematologica. 2025;110:546-561.
    PubMed     Abstract available
    
    
    
15. GOTARDO EMF, Torres LS, Zaidan BC, Gushiken LFS, et al
    Targeting P-selectin and interleukin-1beta in mice with sickle cell disease: effects on vaso-occlusion, liver injury and organ iron deposition.
    Haematologica. 2025;110:725-738.
    PubMed     Abstract available
    
    
    January 2025
16. QUINN CT, Ware RE
    The modern use of hydroxyurea for children with sickle cell anemia.
    Haematologica. 2025 Jan 9. doi: 10.3324/haematol.2023.284633.
    PubMed     Abstract available
    
    
    
17. STEINBERG-SHEMER O, Goldberg TA, Yacobovich J, Levin C, et al
    Erratum to: Characterization and genotype-phenotype correlation of patients with Fanconi anemia in a multi-ethnic population.
    Haematologica. 2025;110:264-265.
    PubMed    
    
    
    December 2024
18. EL HOSS S, Shangaris P, Brewin J, Psychogyiou ME, et al
    Reduced GATA1 levels are associated with ineffective erythropoiesis in sickle cell anemia.
    Haematologica. 2024 Dec 5. doi: 10.3324/haematol.2024.286010.
    PubMed     Abstract available
    
    
    November 2024
19. OLIVIER E, Zhang S, Yan Z, Bouhassira EE, et al
    Erratum to: Stem cell factor and erythropoietin-independent production of cultured reticulocytes.
    Haematologica. 2024;109:3829-3831.
    PubMed    
    
    
    October 2024
20. SALIMBENI AF, De Rosa L, Volpato A, Viaro F, et al
    Posterior cerebral circulation in children with sickle cell anemia: an uncharted territory.
    Haematologica. 2024 Oct 24. doi: 10.3324/haematol.2024.285773.
    PubMed     Abstract available
    
    
    
21. ABBOUD MR
    Cerebral vasculopathy in patients with sickle cell disease and stroke: now you see it, now you don't.
    Haematologica. 2024;109:3108-3109.
    PubMed    
    
    
    
22. LINGUET SL, Verlhac S, Missud F, Holvoet-Vermaut L, et al
    Stroke without cerebral arteriopathy in sickle cell disease children: causes and treatment.
    Haematologica. 2024;109:3346-3356.
    PubMed     Abstract available
    
    
    September 2024
23. RUSSO G, Colombatti R
    Are we ready for new strategies to prevent stroke in children with sickle cell disease?
    Haematologica. 2024;109:2767-2768.
    PubMed    
    
    
    
24. PANTOPOULOS K
    Oral iron supplementation: new formulations, old questions.
    Haematologica. 2024;109:2790-2801.
    PubMed     Abstract available
    
    
    
25. DE LIGT LA, Fijnvandraat K, Biemond BJ, Heijboer H, et al
    Withholding transfusion therapy in children with sickle cell disease with abnormal transcranial Doppler and normal magnetic resonance angiography: a retrospective analysis.
    Haematologica. 2024;109:3009-3012.
    PubMed    
    
    
    August 2024
26. QUEIROZ DMM, Braga LLC, Rocha GA, Batista SA, et al
    Infection by Helicobacter pylori cytotoxin-A-associated antigen-positive strains is associated with iron deficiency anemia in a longitudinal birth cohort in Brazil.
    Haematologica. 2024 Aug 22. doi: 10.3324/haematol.2024.285446.
    PubMed     Abstract available
    
    
    
27. MOUGIN L, Riccetti M, Merlet AN, Bartolucci P, et al
    Endurance training improves oxygen uptake/demand mismatch, metabolic flexibility and recovery in patients with sickle cell disease.
    Haematologica. 2024;109:2628-2638.
    PubMed     Abstract available
    
    
    
28. KUMAR J, Lewis NE, Sherpa S, Londono D, et al
    Diagnostic challenges and proposed classification of myeloid neoplasms with overlapping features of thrombocytosis, ring sideroblasts and concurrent del(5q) and SF3B1 mutations.
    Haematologica. 2024;109:2676-2681.
    PubMed    
    
    
    
29. PIEHLER AP, Truger M, Kozik JH, Weissmann S, et al
    Classical meets malignant hematology: a case of acquired epsilongammadeltabeta-thalassemia in clonal hematopoiesis.
    Haematologica. 2024;109:2745-2748.
    PubMed    
    
    
    
30. FARRUKH F, Abdelmagid M, Mangaonkar A, Patnaik M, et al
    Prognostic impact of SF3B1 mutation and multilineage dysplasia in myelodysplastic syndromes with ring sideroblasts: a Mayo Clinic study of 170 informative cases.
    Haematologica. 2024;109:2525-2532.
    PubMed     Abstract available
    
    
    
31. D'ALESSANDRO A, Le K, Lundt M, Li Q, et al
    Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease.
    Haematologica. 2024;109:2639-2652.
    PubMed     Abstract available
    
    
    July 2024
32. WANG P, Jiang W, Lai T, Liu Q, et al
    Germline variants in acquired aplastic anemia: current knowledge and future perspectives.
    Haematologica. 2024 Jul 11. doi: 10.3324/haematol.2023.284312.
    PubMed     Abstract available
    
    
    
33. BROCCIA MV, Vergier J, Benoit A, Huguenin Y, et al
    Pubertal development of transfusion-dependent thalassemia patients in the era of oral chelation with deferasirox: results from the French registry.
    Haematologica. 2024;109:2271-2276.
    PubMed    
    
    
    June 2024
34. MATTE A, Federti E, Recchiuti A, Hamza M, et al
    Epeleuton, a novel synthetic omega-3 fatty acid, reduces hypoxia/ reperfusion stress in a mouse model of sickle cell disease.
    Haematologica. 2024;109:1918-1932.
    PubMed     Abstract available
    
    
    May 2024
35. QUDEIMAT A, Suryaprakash S, Madden R, Srinivasan A, et al
    Reduced toxicity conditioning for hematopoietic stem cell transplantation in children with Diamond-Blackfan anemia.
    Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285147.
    PubMed     Abstract available
    
    
    
36. KOO J, Howell JC, Hornung L, Sabulski A, et al
    Infrequent fractures and resilient bone mineral density: bone health in patients with Fanconi anemia.
    Haematologica. 2024 May 30. doi: 10.3324/haematol.2024.285612.
    PubMed     Abstract available
    
    
    
37. ZAHR RS, Rashkin SR, Ruiz MA, Elsherif L, et al
    Soluble urokinase plasminogen activator receptor is associated with kidney disease and its progression in sickle cell anemia.
    Haematologica. 2024 May 2. doi: 10.3324/haematol.2023.284920.
    PubMed     Abstract available
    
    
    
38. PECKER LH, Federspiel J
    Sickle cell disease, pregnancy, and COVID-19 in France: plus ca change.
    Haematologica. 2024;109:1328-1330.
    PubMed    
    
    
    
39. KAMINSKI TW, Katoch O, Li Z, Hanway CB, et al
    Impaired hemoglobin clearance by sinusoidal endothelium promotes vaso-occlusion and liver injury in sickle cell disease.
    Haematologica. 2024;109:1535-1550.
    PubMed     Abstract available
    
    
    
40. JOSEPH L, De Luna G, Bernit E, Cougoul P, et al
    A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.
    Haematologica. 2024;109:1562-1565.
    PubMed    
    
    
    April 2024
41. CONNOR MP, Prathapa N, Frey NV, Gill SI, et al
    Hypomethylating agents are associated with high rates of hematologic toxicity in patients with secondary myeloid neoplasms developing after acquired aplastic anemia.
    Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285275.
    PubMed     Abstract available
    
    
    
42. GLENTHOJ A
    Beyond adenosine triphosphate: unveiling the pleiotropic effects of pyruvate kinase activation in sickle cell anemia.
    Haematologica. 2024 Apr 18. doi: 10.3324/haematol.2024.285390.
    PubMed     Abstract available
    
    
    
43. OLIVIER E, Zhang S, Yan Z, Bouhassira EE, et al
    Stem cell factor and erythropoietin-independent production of cultured reticulocytes.
    Haematologica. 2024 Apr 11. doi: 10.3324/haematol.2023.284427.
    PubMed     Abstract available
    
    
    
44. DENIS M, Swartzrock L, Willner H, Bubb QR, et al
    Hematopoiesis post anti-CD117 monoclonal antibody treatment in wild-type and Fanconi anemia settings.
    Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284275.
    PubMed     Abstract available
    
    
    
45. BOSE P, Masarova L, Pemmaraju N, Bledsoe SD, et al
    Sotatercept for anemia of myelofibrosis: a phase II investigator-initiated study.
    Haematologica. 2024 Apr 4. doi: 10.3324/haematol.2023.284078.
    PubMed    
    
    
    
46. DUBEY RK, Vats R, Brzoska T, Kaminski TW, et al
    Subcutaneous injection of IHP-102 prevents lung vaso-occlusion in sickle cell disease mice.
    Haematologica. 2024;109:1259-1263.
    PubMed    
    
    
    March 2024
47. ZHANG Q, Lin P, Mao A, Liu Y, et al
    An unusual case of thalassemia intermedia with inheritable complex repeats detected by single-molecule optical mapping.
    Haematologica. 2024;109:1000-1006.
    PubMed    
    
    
    
48. AL-SAMKARI H, Grace RF, Glenthoj A, Andres O, et al
    Bone mineral density in adult patients with pyruvate kinase deficiency on long-term mitapivat treatment.
    Haematologica. 2024;109:963-967.
    PubMed    
    
    
    
49. RISITANO AM, Frieri C
    Understanding pharmacological complement inhibition in paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2024;109:704-708.
    PubMed    
    
    
    
50. KULASEKARARAJ AG, Lehtinen AE, Forsyth C, Gandhi S, et al
    Phase II trials of zilucoplan in paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2024;109:929-935.
    PubMed    
    
    
    February 2024
51. LU Y, Zhu Q, Wang Y, Luo M, et al
    Enhancement of PRMT6 binding to a novel germline GATA1 mutation associated with congenital anemia.
    Haematologica. 2024 Feb 22. doi: 10.3324/haematol.2023.284183.
    PubMed     Abstract available
    
    
    
52. XU ZL, Xu LP, Zhang YC, Zhou YH, et al
    The outcome and predictive model of allogeneic hematopoietic stem cell transplantation among elderly patients with severe aplastic anemia from the Chinese Blood and Marrow Transplant Registry Group.
    Haematologica. 2024 Feb 1. doi: 10.3324/haematol.2023.284581.
    PubMed     Abstract available
    
    
    
53. LIU Y, Zhuang Y, Chen J, Zhong Z, et al
    Quantitative evaluation of the clinical severity of hemoglobin H disease in a cohort of 591 patients using a scoring system based on regression analysis.
    Haematologica. 2024;109:632-638.
    PubMed    
    
    
    January 2024
54. FOUDA RT, Cherukury HM, Kiven SB, Garcia NR, et al
    Colchicine reduces inflammation in a humanized transgenic murine model of sickle cell disease.
    Haematologica. 2024;109:308-311.
    PubMed    
    
    
    
55. THILAKARATHNE S, Jayaweera UP, Premawardhena A
    Unresolved laboratory issues of the heterozygous state of beta-thalassemia: a literature review.
    Haematologica. 2024;109:23-32.
    PubMed     Abstract available
    
    
    December 2023
56. RAJPUT RV, Shah V, Shalhoub RN, West-Mitchell K, et al
    Granulocyte transfusions in severe aplastic anemia.
    Haematologica. 2023 Dec 7. doi: 10.3324/haematol.2023.283826.
    PubMed     Abstract available
    
    
    
57. D'ALESSANDRO A, Nouraie SM, Zhang Y, Cendali F, et al
    Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment.
    Haematologica. 2023;108:3418-3432.
    PubMed     Abstract available
    
    
    
58. COLOMBATTI R, Casale M
    Early splenectomy in sickle cell disease: another piece of the puzzle.
    Haematologica. 2023;108:3197-3198.
    PubMed    
    
    
    
59. YAMASHITA D, Muramatsu H, Narita A, Wakamatsu M, et al
    Hematological abnormalities in Jacobsen syndrome: cytopenia of varying severities and morphological abnormalities in peripheral blood and bone marrow.
    Haematologica. 2023;108:3438-3443.
    PubMed    
    
    
    November 2023
60. ESPERTI S, Nader E, Stier A, Boisson C, et al
    Increased retention of functional mitochondria in mature sickle red blood cells is associated with increased sickling tendency, hemolysis and oxidative stress.
    Haematologica. 2023;108:3086-3094.
    PubMed     Abstract available
    
    
    
61. TEFFERI A, Pardanani A, Gangat N
    Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis.
    Haematologica. 2023;108:2919-2932.
    PubMed     Abstract available
    
    
    October 2023
62. GUERRA A, Parhiz H, Rivella S
    Novel potential therapeutics to modify iron metabolism and red cell synthesis in diseases associated with defective erythropoiesis.
    Haematologica. 2023;108:2582-2593.
    PubMed     Abstract available
    
    
    
63. KALLEDA N, Flace A, Altermatt P, Ingoglia G, et al
    Ferroportin inhibitor vamifeport ameliorates ineffective erythropoiesis in a mouse model of beta-thalassemia with blood transfusions.
    Haematologica. 2023;108:2703-2714.
    PubMed     Abstract available
    
    
    
64. VERSTOVSEK S, Foltz L, Gupta V, Hasserjian R, et al
    Safety and efficacy of zinpentraxin alfa as monotherapy or in combination with ruxolitinib in myelofibrosis: stage I of a phase II trial.
    Haematologica. 2023;108:2730-2742.
    PubMed     Abstract available
    
    
    September 2023
65. DEZERN AE, Zahurak M, Jones RJ, Brodsky RA, et al
    Uniform conditioning regardless of donor in bone marrow transplantation for severe aplastic anemia.
    Haematologica. 2023 Sep 7. doi: 10.3324/haematol.2023.284022.
    PubMed     Abstract available
    
    
    
66. BROUSSE V, Bernaudin F, Melaine A, Goguillot M, et al
    Severity and burden of sickle cell disease in France: a nationwide real-world study.
    Haematologica. 2023;108:2476-2486.
    PubMed     Abstract available
    
    
    
67. MATTE A, Kosinski PA, Federti E, Dang L, et al
    Mitapivat, a pyruvate kinase activator, improves transfusion burden and reduces iron overload in beta-thalassemic mice.
    Haematologica. 2023;108:2535-2541.
    PubMed    
    
    
    August 2023
68. GRIFFIN M, Eikema DJ, Verheggen I, Kulagin A, et al
    SARS-CoV-2 vaccination in 361 non-transplanted patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2023 Aug 16. doi: 10.3324/haematol.2023.283863.
    PubMed    
    
    
    
69. CIUDAD M, Ouandji S, Lamarthee B, Cladiere C, et al
    Regulatory T-cell dysfunctions are associated with increase in tumor necrosis factor alpha in autoimmune hemolytic anemia and participate in Th17 polarization.
    Haematologica. 2023 Aug 3. doi: 10.3324/haematol.2023.282859.
    PubMed     Abstract available
    
    
    July 2023
70. BACIGALUPO A
    Long term survivors in severe aplastic anemia: standard mortality rates now comparable to controls?
    Haematologica. 2023 Jul 13. doi: 10.3324/haematol.2023.283523.
    PubMed     Abstract available
    
    
    
71. ALKOBTAWI M, Sbeih M, Souaid K, Ngo QT, et al
    Contribution of fetal microchimeric cells to maternal wound healing in sickle cell ulcers.
    Haematologica. 2023;108:1920-1933.
    PubMed     Abstract available
    
    
    June 2023
72. DROR Y
    Correcting the aberrant Fanconi anemia transcriptional program by gene therapy.
    Haematologica. 2023 Jun 8. doi: 10.3324/haematol.2023.283031.
    PubMed     Abstract available
    
    
    
73. NAKAMURA R, Patel BA, Kim S, Wong FL, et al
    Conditional survival and standardized mortality ratios of patients with severe aplastic anemia surviving at least one year after hematopoietic cell transplantation or immunosuppressive therapy.
    Haematologica. 2023 Jun 1. doi: 10.3324/haematol.2023.282781.
    PubMed     Abstract available
    
    
    May 2023
74. MECHRAOUI A, Ithier G, Pages J, Haouari Z, et al
    Early splenectomy in a large cohort of children with sickle cell anemia: risks and consequences.
    Haematologica. 2023 May 25. doi: 10.3324/haematol.2022.282556.
    PubMed     Abstract available
    
    
    
75. LIU Y, Schmiderer L, Hjort M, Lang S, et al
    Engineered human Diamond-Blackfan anemia disease model confirms therapeutic effects of clinically applicable lentiviral vector at single-cell resolution.
    Haematologica. 2023 May 18. doi: 10.3324/haematol.2022.282068.
    PubMed     Abstract available
    
    
    
76. PAGLIUCA S, Kulasekararaj AG, Eikema DJ, Piepenbroek B, et al
    Current use of androgens in bone marrow failure disorders: a report from the Severe Aplastic Anemia Working Party of the European Society of Blood and Marrow Transplantation.
    Haematologica. 2023 May 18. doi: 10.3324/haematol.2023.282935.
    PubMed     Abstract available
    
    
    
77. FEDERTI E, Vinchi F, Iatcenko I, Ghigo A, et al
    Duality of Nrf2 in iron-overload cardiomyopathy.
    Haematologica. 2023;108:1335-1348.
    PubMed     Abstract available
    
    
    
78. ATAGA KI, Zhou Q, Saraf SL, Hankins JS, et al
    Sex differences in progression of kidney disease in sickle cell disease.
    Haematologica. 2023;108:1436-1441.
    PubMed    
    
    
    
79. WANG L, Liu S, Luo J, Mo Q, et al
    Targeting a thrombopoietin-independent strategy in the discovery of a novel inducer of megakaryocytopoiesis, DMAG, for the treatment of thrombocytopenia.
    Haematologica. 2023;108:1394-1411.
    PubMed     Abstract available
    
    
    
80. KULASEKARARAJ A, Brodsky R, Kulagin A, Jang JH, et al
    Biosimilars in rare diseases: a focus on paroxysmal nocturnal hemoglobinuria.
    Haematologica. 2023;108:1232-1243.
    PubMed     Abstract available
    
    
    April 2023
81. ROSATO BE, Marra R, Del Giudice F, Nostroso A, et al
    One gene, two opposite phenotypes: a case report of hereditary anemia due to a loss-offunction variant in the EPAS1 gene.
    Haematologica. 2023 Apr 27. doi: 10.3324/haematol.2022.282457.
    PubMed     Abstract available
    
    
    
82. LASAGA M, Rio P, Vilas-Zornoza A, Planell N, et al
    Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.
    Haematologica. 2023 Apr 6. doi: 10.3324/haematol.2022.282418.
    PubMed     Abstract available
    
    
    
83. NARDO-MARINO A, Brousse V
    Splenectomy in sickle cell disease: do benefits outweigh risks?
    Haematologica. 2023;108:954-955.
    PubMed    
    
    
    
84. PINTO VM, Gianesin B, Piel FB, Longo F, et al
    Morbidity and mortality of sickle cell disease patients is unaffected by splenectomy: evidence from three decades of follow-up in a high-income setting.
    Haematologica. 2023;108:1158-1162.
    PubMed    
    
    
    March 2023
85. DEVILLIER R, Eikema DJ, Dufour C, Aljurf M, et al
    Graft-versus-host disease and relapse/rejection-free survival after allogeneic transplantation for idiopathic severe aplastic anemia: a comprehensive analysis from the SAAWP of the EBMT.
    Haematologica. 2023 Mar 23. doi: 10.3324/haematol.2022.281876.
    PubMed     Abstract available
    
    
    
86. KOO J, Grom-Mansencal I, Howell JC, Rios JM, et al
    Gonadal function in pediatric Fanconi anemia patients treated with hematopoietic stem cell transplant.
    Haematologica. 2023 Mar 9. doi: 10.3324/haematol.2022.282094.
    PubMed     Abstract available
    
    
    
87. GALINDO-NAVARRO P, Delgado-Garcia A, Rodriguez-Gil MA, Puerta-Puerta JM, et al
    Venetoclax for treating refractory autoimmune hemolytic anemia in chronic lymphocytic leukemia: report of two cases in Spain.
    Haematologica. 2023 Mar 2. doi: 10.3324/haematol.2022.281850.
    PubMed     Abstract available
    
    
    
88. JASH A, Howie HL, Hay AM, Luckey CJ, et al
    Identification of multiple genetic loci associated with red blood cell alloimmunization in mice.
    Haematologica. 2023;108:905-908.
    PubMed    
    
    
    
89. FALGUIERE C, Allali S, Khazem B, Kamdem A, et al
    Delayed hemolytic transfusion reaction in children with sickle cell disease: first 5-year retrospective study in mainland France.
    Haematologica. 2023;108:889-894.
    PubMed    
    
    
    
90. PINCEZ T, Lo KS, D'Orengiani APHD, Garrett ME, et al
    Variation and impact of polygenic hematologic traits in monogenic sickle cell disease.
    Haematologica. 2023;108:870-881.
    PubMed     Abstract available
    
    
    
91. CONRAN N
    Pain mechanisms in sickle cell disease. Are we closer to a breakthrough?
    Haematologica. 2023;108:663-664.
    PubMed    
    
    
    
92. KHASABOVA IA, Gable J, Johns M, Khasabov SG, et al
    Inhibition of DAGLbeta as a therapeutic target for pain in sickle cell disease.
    Haematologica. 2023;108:859-869.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Anemia is free of charge.